Immunogenomics: Understanding the immune response to disease
This advanced-level course explores the molecular and genetic basis of cancer, its progression, and associated immune responses.
£310.00
Starts 14th September 2026
Immunogenomics: Understanding the immune response to disease
This advanced-level course explores the molecular and genetic basis of cancer, its progression, and associated immune responses.
£310.00
Starts 14th September 2026
About This Course
- 14 Modules
- 30 Hours
- Level: Advanced
- Language: English
- Course Type: Self-paced
- CPD Accredited Certificate
- Online Learning
Who Is This Course For
This course is ideal for professionals with a background in biosciences, oncology, genetics, immunology, or related fields. It is suitable for undergraduate or postgraduate students, researchers, lecturers, professors, policymakers, and industry professionals interested in immunogenomics. The course references key research papers from reputable, peer-reviewed journals, providing valuable insights for researchers in the field. It also highlights career opportunities in immunogenomics, offering guidance for those pursuing a career in this area.
What you'll learn
- Learn about the genetic basis of cancer and the immune response elicited by the body.
- Understand the mechanisms of antigen presentation, immune activation, and exhaustion.
- Learn about the role of biomarkers in immunotherapy development.
- Develop a strong understanding of concepts such as immunogenotyping and immunophenotyping.
- Learn about the development of CAR-T therapies, their mechanism of action, clinical applications, and side effects.
Course Content
Meet Your Instructor
Dr. Christos Evangelou
Ph.D. in Cancer Biology, Division of Molecular and Clinical Cancer Sciences, University of Manchester, UK. Areas of expertise include cancer immunology, melanoma research, cancer immunotherapy, and mechanisms of immunotherapy resistance. During my Ph.D. research, I studied the role of chronic inflammation and cytokine IFN-gamma in adaptation and immunotherapy resistance in melanoma. By integrating high-throughput transcriptomic analyses and employing various cancer cell lines and animal models, I have developed methods to predict response to immunotherapy in melanoma patients. During my research, I have used the CRISPR/Cas9 system to knockout genes in human and mouse cell lines to assess the role of certain genes in immunotherapy resistance in melanoma.
Dr. Veronica Hughes
Veronica Hughes received her Ph.D. in medical science from the University of Florida. Her primary interest was cancer metastasis, dysregulation of the tumour microenvironment, and analysis of clinical trial design. Additionally, she engaged in the development of novel small animal models.
Dr. Matthias Schröder
Ph.D. in Immunology at the Division of Immunopharmacology of the University Clinic of Frankfurt am Main. Involved in basic and applied research for immunological interventions to treat cancer for 13 years. Matthias used a high-throughput CRISPR/Cas9 approach to generate a library of knockout cells that could be differentiated into immunosuppressive cells to investigate the potential loss of function situations. Currently involved in the development of fusion proteins to activate receptors of the TNF-superfamily (CD40, CD27, etc.) at a small German Biotech company as Head of Assay Development.
Our Partners
We are proud to partner with the leading In2scienceUK as a step towards achieving our mission of imparting quality education and knowledge across the globe.
How This Course Supports Your Career Development
Biotechnology is one of the fastest-evolving industries in the world, creating demand for professionals with knowledge of emerging fields such as genomics, gene therapy, bioinformatics, artificial intelligence and precision medicine.
Our learners include students, graduates, researchers and professionals from leading universities, pharmaceutical companies, biotechnology organisations and research institutions across the UK and internationally.
Upon successful completion, learners receive a CPD-accredited certificate and earn recognised CPD hours that can be included on CVs, LinkedIn profiles, professional portfolios and CPD records.
By completing this course, you will strengthen your scientific knowledge, earn valuable CPD hours and demonstrate a commitment to continuous professional development within the life sciences sector.
INTERESTED IN THIS COURSE FOR YOUR ORGANISATION?
Empower your teams and students with cutting-edge learning in today’s most sought-after scientific and technical domains through CBEHx for Business and School.
Equip your organisation with rigorous, science-based training designed to strengthen technical proficiency and drive innovation across research and industry.
Empower educators and students through high-quality science education supported by digital learning tools and measurable outcomes.
Common articles
Do you have any question? Please visit our Help Centre
Grow better with the right option, click here to view pricing.
Usually, there are no general prerequisites when enrolling for any individual courses on cbehx.co.uk. However, some courses are certainly more advanced than others that are of introductory and intermediate level. For advanced-level courses, prior knowledge on the topic will be helpful for understanding complex concepts but not mandatory.
The relevant information about the suggested knowledge and background that might be helpful to follow each course is provided on the respective course registration page.
Yes, the courses are flexible and self-paced to suit your schedule. The term “self-paced” implies that the courses do not follow a pre-assigned schedule for learning within the course duration. You will be able to access all the course materials for each course that you have enrolled in as soon as the course begins.
The course completion certificate is CPD accredited. For more informations please visit https://cpduk.co.uk
